Client News
Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares
14th March 2024
HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell
14th March 2024
Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the development of its ADC Pipeline
14th March 2024
Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment for Out-Licensing
14th March 2024
Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca
14th March 2024
Bayer and Aignostics to collaborate on next generation precision oncology
14th March 2024
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence
12th March 2024
FYB201/Ranibizumab keeps gaining momentum with approvals and launches in the MENA region
11th March 2024
MIG Capital: MIG Capital leads €5 million Series A financing of animal healthcare company HawkCell to democratise MRI imaging
11th March 2024
Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024isease transgenic model to be presented at AD/PD™ 2024 Conference
8th March 2024
There is no more content to load